Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy
出版年份 2019 全文链接
标题
Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-01-23
DOI
10.3389/fonc.2019.00017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Patient-derived organoid models help define personalized management of gastrointestinal cancer
- (2018) M. R. Aberle et al. BRITISH JOURNAL OF SURGERY
- Ev vivo organ culture as potential prioritization tool for breast cancer targeted therapy
- (2018) Albert Grinshpun et al. CANCER BIOLOGY & THERAPY
- Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics
- (2018) Carmela Ricciardelli et al. CANCER LETTERS
- Establishment of patient-derived tumor spheroids for non-small cell lung cancer
- (2018) Zengli Zhang et al. PLoS One
- The Generation and Application of Patient-Derived Xenograft Model for Cancer Research
- (2018) Jaeyun Jung et al. Cancer Research and Treatment
- Multicellular spheroid based on a triple co-culture: A novel 3D model to mimic pancreatic tumor complexity
- (2018) Gianpiero Lazzari et al. Acta Biomaterialia
- Affinity of human IgG subclasses to mouse Fc gamma receptors
- (2017) Gillian Dekkers et al. mAbs
- Patient-derived xenografts as in vivo models for research in urological malignancies
- (2017) Takahiro Inoue et al. Nature Reviews Urology
- Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- (2017) Chantal Pauli et al. Cancer Discovery
- Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care
- (2017) David P. Kodack et al. Cell Reports
- Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma
- (2016) D. Roife et al. CLINICAL CANCER RESEARCH
- Omics for personalized medicine: defining the current we swim in
- (2016) Rania Ibrahim et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- The possibility of clinical sequencing in the management of cancer
- (2016) Tadayuki Kou et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Patient-derived xenografts: a relevant preclinical model for drug development
- (2016) Luca Pompili et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer
- (2016) Taofeek K. Owonikoko et al. Journal of Translational Medicine
- Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
- (2016) Shanthi Marur et al. MAYO CLINIC PROCEEDINGS
- Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway Inflammation
- (2016) Shirin Elhaik Goldman et al. PLoS One
- Changing paradigm of cancer therapy: precision medicine by next-generation sequencing
- (2016) Yuan Xue et al. Cancer Biology & Medicine
- Organoid Models of Human and Mouse Ductal Pancreatic Cancer
- (2015) Sylvia F. Boj et al. CELL
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
- (2015) Biswanath Majumder et al. Nature Communications
- Ex Vivo Antibody-Dependent Cellular Cytotoxicity Inducibility Predicts Efficacy of Cetuximab
- (2015) Rodney J. Taylor et al. Cancer Immunology Research
- Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes
- (2015) Rami Yossef et al. PLoS One
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
- (2013) M M Gerlach et al. BRITISH JOURNAL OF CANCER
- Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: Implications for the hosts’ innate immune response
- (2013) Kiran Kundu et al. CELLULAR IMMUNOLOGY
- Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice
- (2013) Marina Bersudsky et al. GUT
- Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses
- (2013) Darren R Tyson et al. Personalized Medicine
- Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies
- (2012) Lisa Licitra et al. EUROPEAN JOURNAL OF CANCER
- Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus
- (2012) Kui Chen et al. PLoS One
- Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study
- (2010) L. Licitra et al. ANNALS OF ONCOLOGY
- Head and neck cancer
- (2010) David M. Cognetti et al. CANCER
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now